Decreased expression of p33ING1 mRNA in lymphoid malignancies

American Journal of Hematology

Volumn 62, Issue 2, 1999, Pages 118-119

  Ohmori, M ^a   Nagai, M ^a   Tasaka, T ^a   Koeffler, H P ^b   Riabowol, K ^c   Takahara, J ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

13q34; Lymphoma; p33ING1; p53

Indexed keywords

PROTEIN P53;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA SEQUENCE; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN CELL; LYMPHOMA; MONONUCLEAR CELL; PRIORITY JOURNAL; RNA TRANSCRIPTION; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GROWTH INHIBITORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JURKAT CELLS; LEUKEMIA; LYMPHOMA; NUCLEAR PROTEINS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0032828709     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199910)62:2<118::AID-AJH11>3.0.CO;2-X     Document Type: Article

References (7)

1. Garkavtsev I, Kazarov A, Gudkov A, Riabowol K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastie transformation. Nature Genet 1996;14:415-420.
2. Garkavtsev I, Demetrick D, Riabowol, K. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1). Cytogenet Cell Genet 1997;76:176-178.
3. Garkavtsev I, Riabowol K. Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor. Mol Cell Biol 1997;17:2014-2019.
4. Berger R, Le Coniat M, Derre J, Vecchione D. Secondary nonrandom chromosomal abnormalities of band 13q34 in Burkitt lymphoma-leukemia. Genes Chromosomes Cancer 1989;2:115-118.
5. Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole DH, Sawyer JR. Poor prognosis in multiple myeloma is associated with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 1995; 86:4250-4256.
6. Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM, Gudkov AV. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature 1998;391:295-298.
7. Helbing CC, Veillette C, Riabowol K, Johnston RN, Garkavtsev I. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. Cancer Res 1997;57:1255-1258.